News Stories Related to Treatments
- Chemotherapy Option for Mesothelioma Patients
- Spotlight on The University of Chicago Cancer Research Center Mesothelioma Program
- Dietary Suggestions for Managing Inflammation with Asbestosis and Mesothelioma
- Chronomodulated Chemotherapy May Offer Additional Options for Mesothelioma Treatments
- Hypnosis Can Be Useful for Pain Management in Mesothelioma
- Mesothelioma Patients Sought for Clinical Trial
- Specialized Treatment Offers Hope for Mesothelioma Prognoses
- Study: Pleurectomy/Decortication Effective in Multimodal Therapy for Mesothelioma
- Gene Expression and Treatment Prognosis in Malignant Mesothelioma
- Researchers Confirm Chromosome Deletion Among Mesothelioma Patients
- MesotheliomaHelp.net Announces Expanded Information on Mesothelioma and Lung Cancer Specialists
- New Clinical Trial for Treatment of Mesothelioma
- Researchers Target Mesothelioma Cells in Mice
- Malignant Pleural Mesothelioma and Chemotherapy with Belinostat (Phase II Study)
- Pleural Mesothelioma and Surgery
- Implant Raises Cellular Army to Attack Cancer
- Mesothelioma Research at the Minnesota Partnership for Biotechnology and Medical Genomics
- Finding Chemo: Scanning the Sea Floor for New Drugs
- Chemoembolisation for Pleural Mesothelioma Treatment
- Gemcitabine Combined With Oxaliplatin in Pretreated Patients with Malignant Pleural Mesothelioma:
- 'Smart bomb' Nanoparticles Stop Cancer's Spread
- Researchers Use Nanotech to Target Chemo Cancer Treatment
- Cancer Stem Cells May Not Be the Supervillains We Thought
- Peritoneal Mesothelioma
- BTG Licenses Novel Anticancer Compound to Onyx Pharmaceuticals
- Malignant Peritoneal Mesothelioma:Results from the International Expanded Access Program Using Pemetrexed Alone or with a Platinum Agent
- WA Researchers Close To Cancer Breakthrough
- MesotheliomaHelp.net Announces Expanded Information on Mesothelioma Treatments
- Grow Your Own: Tissue Engineering Saves Patient's Lung
- Inhibition of Hsp90 Leads to Cell Cycle Arrest and Apoptosis in Human Malignant Pleural Mesothelioma
- Paper in Cell Cycle Reports Alfacell's ONCONASE(R) Targets siRNA
- Treatment of Peritoneal Mesothelioma in Pediatric Patients
- Enhanced Antitumor Therapy by Inhibition of P21 in Human Malignant Mesothelioma
- Lilly says FDA widens use of cancer drug Alimta
- Systemic Treatments for Mesothelioma: Standard and Novel
- Diagnosis, Staging, and Surgical Treatment of Malignant Pleural Mesothelioma
- Consensus Statement on Peritoneal Mesothelioma
- MVP and Vinorelbine for Malignant Pleural Mesothelioma
- Prevention of Malignant Seeding at Drain Sites after Invasive Procedures ... by Hypofractionated Radiotherapy in Patients with Pleural Mesothelioma
- Successful Palliation of Malignant Ascites from Peritoneal Mesothelioma by Laparoscopic Intraperitoneal Hyperthermic Chemotherapy
- Review of Pemetrexed in Combination with Cisplatin for the Treatment of Malignant Pleural Mesothelioma
- Molmed gets US FDA Orphan Drug Status for Malignant Mesothelioma Drug
- Incidence of Atrial Fibrillation after Extrapleural Pneumonectomy versus Pleurectomy in patients with Malignant Pleural Mesothelioma
- Pemetrexed plus Gemcitabine as First-Line Chemotherapy for Patients with Peritoneal Mesothelioma: Final Report of a Phase II Trial
- A Phase II Trial of Tetrathiomolybdate After Surgery for Malignant Mesothelioma: Final Results
- Long-term indwelling pleural catheter (PleurX) for malignant pleural effusion unsuitable for talc pleurodesis
- Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma
- Lung Cancer Trial Targets Asbestos-Related Disease
- Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma
- Molecular targets and targeted therapies for malignant mesothelioma
Mesothelioma is a serious cancer that
occurs in individuals exposed to
asbestos. 
